← Insider buys
MRNA

Moderna, Inc. · Healthcare

Director Noubar Afeyan sold $1.5M of Moderna, Inc.

Sold$1,549,441
$103.30Price
15,000Shares

What MRNA did after the filing

Filed Oct 13Copier in Oct 16
The stock from Mon, Oct 16 open, $95.30
−18.0%
S&P 500, same days
+4.9%

Measured over 30 trading days, to the Nov 28 close.

Traded Wed, Oct 11. Filed Fri, Oct 13, 7:00 PM ET, after the close. Returns use the Oct 16 open and the Nov 28 close. Not investment advice.